Revenue: The sum of all revenue fields included for a company's operating activities.
Ligand Pharmaceuticals Incorporated (LGND) had Revenue of $131.31M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$131.31M |
$52.15M |
|
$10.51M |
|
$120.80M |
|
$119.37M |
|
$11.94M |
|
$51.72M |
|
$63.66M |
|
$17.30M |
|
$53.82M |
|
$53.82M |
|
$52.15M |
|
$0.29M |
|
$11.94M |
|
$47.43M |
|
17.30M |
|
17.76M |
|
$3.02 |
|
$2.94 |
|
| Balance Sheet Financials | |
$237.43M |
|
$15.61M |
|
$549.79M |
|
$787.22M |
|
$16.78M |
|
-- |
|
$69.52M |
|
$86.30M |
|
$700.91M |
|
$230.65M |
|
$700.91M |
|
17.56M |
|
| Cash Flow Statement Financials | |
$49.58M |
|
$-11.68M |
|
$-59.95M |
|
$45.01M |
|
$22.95M |
|
$-22.05M |
|
$25.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.15 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
91.99% |
|
9.09% |
|
9.09% |
|
36.12% |
|
48.48% |
|
39.72% |
|
$46.06M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.44 |
|
3.34 |
|
109.27 |
|
7.68% |
|
23.33% |
|
6.84% |
|
7.68% |
|
$39.92 |
|
$2.59 |
|
$2.79 |
|